Study Links Fine Particulate Pollution to Increased Alzheimer’s Brain Pathology

Researchers in the United States report an association between exposure to fine particulate air pollution (PM2.5) and more advanced Alzheimer’s disease neuropathology in a first-of-its-kind autopsy study.

The team from the University of Pennsylvania assessed 602 brain autopsies performed between 1999 and 2022 across 11 states and matched each decedent’s last known address to modeled one-year average PM2.5 concentrations. They found that for every 1 μg/m3 increase in annual PM2.5 exposure, there was a 17% higher likelihood of greater spread of the toxic proteins amyloid and tau in the brain, a 19% higher likelihood of increased overall Alzheimer disease neuropathologic change, and a 16% increase in the odds of having a large brain infarct.

The researchers reported their findings in JAMA Neurology and wrote that "this study reinforces the finding that PM2.5 exposure appears to negatively affect cognitive function and suggests that this may be mediated by ADNC [Alzheimer disease neuropathologic change]." They added: "Our findings suggest that PM2.5 exposure may exacerbate the development of Alzheimer's disease."

PM2.5 refers to airborne particles with diameters of 2.5 micrometers or smaller, produced by vehicle exhaust, wood burning and other combustion sources. These particles can travel deep into the lungs and enter the bloodstream. The World Health Organization has repeatedly urged governments to reduce air pollution; WHO estimates outdoor and household air pollution contribute to about 7 million premature deaths worldwide each year.

Autopsy-based studies allow direct examination of brain tissue changes that are not visible in clinical records or imaging alone. In this study, researchers used contemporary exposure models to estimate the one-year average PM2.5 concentration at each subject’s address prior to death and then examined the presence and severity of amyloid plaques, tau tangles and large infarcts—pathologic hallmarks associated with Alzheimer's disease and related dementias.

The authors caution that the analysis has limitations. The study did not control for individual lifestyle factors such as physical activity, smoking and alcohol use, nor did it assess exposure to other pollutants such as nitrogen dioxide or ozone, which can co-occur with PM2.5 and may independently affect brain health. The sample, drawn from 11 U.S. states, also may not represent all populations, and the researchers called for additional population-based autopsy studies to generalize the findings.

Previous epidemiological and clinical studies have linked PM2.5 exposure with cognitive decline and increased risks of respiratory and cardiovascular disease. Landmark modeling studies have estimated a rising global burden of dementia that reflects ageing populations and multiple risk factors, and research published in The Lancet has highlighted dozens of potentially modifiable risk factors across the life course.

Public-health experts say the new autopsy evidence adds biological plausibility to earlier associations between air pollution and dementia risk by showing a relationship with the proteins believed to underlie Alzheimer’s symptoms. The study does not prove causation but strengthens calls by health agencies for tighter pollution controls and for further research to clarify mechanisms and susceptible populations.

Alzheimer’s disease is the most common form of dementia and accounts for a large share of dementia-related morbidity and mortality worldwide. Estimates suggest that dementia cases have risen substantially over recent decades; one analysis found new cases of Alzheimer’s and related dementias rose by roughly 148% globally from 1990 to 2019, while total prevalent cases increased by around 161% in that period. In the United Kingdom, Alzheimer’s Research UK and University College London projections have warned of sizeable future increases in the number of people living with dementia as populations age.

The authors and public-health bodies say the findings underscore the potential value of pollution reduction as part of broader dementia-prevention strategies, while underscoring the need for further research to account for lifestyle, socioeconomic and co-pollutant factors and to determine whether reducing PM2.5 exposure can slow the development of Alzheimer’s-related pathology.